Results 221 to 230 of about 12,579 (242)

Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine—Reply

JAMA, 2023
Aniruddha, Hazra, John A, Schneider
openaire   +2 more sources

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection.

Current opinion in molecular therapeutics, 2008
Bavarian Nordic is developing IMVAMUNE, which is based on a live attenuated modified vaccinia Ankara virus, for the potential prevention of smallpox infection, particularly in those patients contraindicated to traditional smallpox vaccines, such as the immunocompromised and those with eczema or dermatitis.
openaire   +1 more source

Enhancing global access to cancer medicines

Ca-A Cancer Journal for Clinicians, 2020
Javier Cortes, Giuseppe Curigliano, Nagi S El Saghir   +2 more
exaly  

Epstein–Barr virus and multiple sclerosis

Nature Reviews Microbiology, 2022
Samantha S Soldan, Paul M Lieberman
exaly  

Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract

Nature Reviews Microbiology, 2021
David F Boyd, Victoria A Meliopoulos, Paul G. Thomas   +2 more
exaly  

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Harrys A Torres, Roy F Chemaly, Nassim Hammoudi   +2 more
exaly  

The impact of comorbidity on cancer and its treatment

Ca-A Cancer Journal for Clinicians, 2016
Diana Sarfati, Bogda Koczwara
exaly  

The role of human papillomavirus in nongenital cancers

Ca-A Cancer Journal for Clinicians, 2013
Dan P Zandberg
exaly  

Bat-borne virus diversity, spillover and emergence

Nature Reviews Microbiology, 2020
Michael Letko, Stephanie N Seifert, Kevin J Olival   +2 more
exaly